Dr. Engber’s work in neuroscience spans three decades and includes research and leadership positions at the NIH, Cephalon, Pfizer, Biogen and most recently Takeda, where he was responsible for evaluating new technologies and advancing the company’s CNS portfolio through partnerships.
January 23, 2018
· 2 min read